Full Text View
Tabular View
No Study Results Posted
Related Studies
Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation
This study has been completed.
Study NCT00642655   Information provided by Cedars-Sinai Medical Center

First Received on March 19, 2008.   Last Updated on March 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Transplant
Interventions listed in this trial
IVIG and Rituximab
Additional drug interventions recognized in this trial
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
Rituximab
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Cedars-Sinai Medical Center
Genentech
Biogen Idec


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services